In terms of geographical segmentation, the global heart valve devices market is being led by the regional segment of North America. The US market is particularly the biggest contributing segment for the dominance of the North America market. The US heart valve devices market is the biggest one across the globe and is expected to continue to dominate in the coming years of the forecast period. Positive results from the multiple clinical trials and studies are expected to continue to propel the heart valve market. The leading companies in the global market are now trying to secure considerable market share and expand it by launching more clinical studies and acquiring smaller players with innovative technologies and devices in their portfolio. This has become modus operandi for bigger players operating in the global heart valve devices market. In addition to this, new devices as well as device types are expected to continue to emerge in the near future and cater to newer patient demands. These factors are thus projected to help the development of the global market in the coming years of the forecast period ranging from 2017 to 2025.

However, in recent months, the outbreak of COVID-19 has considerably impacted the overall development of the global market. The lockdowns and other restrictions have resulted in losing out on procedural volumes in the short term. But the global market looks to be in the phase of gradual recovery as the world economy opens up. The companies operating in the market had to initially shift focus on stemming the spread of the virus by adhering to strict regulations. However, with the new vaccine on the horizon, the companies in the global heart valve market are expecting to get back to some form of normalcy by the second half of 2021 and also recover the initially projected growth rate.

Global Heart Valve Devices Market: Snapshot

On account of the presence of a copious number of manufacturers, the global heart valve devices market is fragmented in nature. Players in the market are seen competing with one another either on the basis of a diverse product portfolio or on the basis of specific products. A report by Transparency Market Research predicts the competition in the market to heat up further in the years to come on account of the foray of aspiring manufacturers.

Majorly fuelling growth in the global market for heart valve devices market is the increasing instances of obesity and unhealthy lifestyle causing various cardiac diseases and pathological disorders. In addition, the increasing demand for minimally invasive procedures and continued product modifications by leveraging the latest technologies developments have brought about more effective heart valve devices. This has also had a positive impact on the market.

As per Transparency Market Research, the global heart valve devices market will likely register a CAGR of 12.4% during the period from 2017 to 2025. Rising at this pace, the market which was worth US$5.8 bn in 2016 will likely become worth US$16.2 bn in 2025.

global heart valve devices market

More than Average Selling Prices of Transcatheter Heart Valves Makes them Dominant Segment

Based on the various types of heart valve devices available in the market, the main segments are mechanical heart valves, biological heart valves, and transcatheter heart valves. Among them, the segment of transcatheter heart valve devices accounts for maximum share in the market. In the foreseeable future too, the segment is expected to retain its dominant share on the back of growing uptake of technologically superior products in developed nations, more than average selling prices, and considerably lower mortality rate achieved by the devices. The mechanical heart valves segment can be further divided into aortic valves and mitral valves. Of them, the segment of transcatheter mitral valves will likely see maximum number of product launches by 2025.

Meanwhile, mechanical heart valve devices are seeing their demand grow in developing countries as these products offer longer life expectancy if anticoagulation is ensured. The biological heart valves, on the other hand, are predicted to grow at a healthy clip in the near future. However, the segment faces threat from substitutes on account of new technologies such as valves made up of bio absorbable polymer scaffolds that provide therapeutic healing to be launched soon.

Improving Healthcare Infrastructure Drives Maximum Growth in Asia Pacific

From a geographical standpoint, North America leads the global heart valve devices market because of the greater uptake of technologically superior products and techniques and comparatively greater average selling prices of heart valve devices in the region. By expanding at a CAGR of 12.4% during the period between 2017 and 2025, the region will likely become worth US$6.92 bn in terms of revenue.

Europe trails North America in the global heart valve devices market vis-à-vis market share. The region’s growth has been mainly brought about by the numerous product launches, supportive policies of the government, and a large pool of elderly highly susceptible to various heart diseases. In terms of growth rate, however, Asia Pacific is expected to overtake other regions by registering a CAGR of 13.3% in the forecast period. The region’s growth will be mainly brought about by the high occurrence of heart valve diseases and an improving healthcare infrastructure.

Some of the prominent participants in the global heart valve devices market are Abbott, CryoLife, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation, TTK HealthCare, JenaValve Technology, Inc., Medtronic, Neovasc, Inc., Sorin Group, Micro Interventional Devices, Inc., and Lepu Medical Technology Co., Ltd.

Global Heart Valve Devices Market: Overview

The global heart valves devices market is witnessing an upward trend due to the increasing prevalence of obesity and adoption of unhealthy lifestyle choices leading to cardiovascular diseases and pathological disorders. Heart valve devices are used for repairing and replacing heart valves sans the need for open surgery. The acceptance of heart valve devices is likely to surge as new devices continue to receive approval from the Food and Drug Administration.

The global market for heart valve devices could be segregated on the basis of type, end-user, and region, where the transcatheter heart valve devices by type is predicted to retain the leading share. The preference of physicians and satisfactory outcomes account for high adoption of transcatheter heart valves devices. Transcatheter devices are used to repair and replace heart valves sans the need for open heart surgery.

The report prepared by seasoned analysts provides a comprehensive analysis of the worldwide heart valve devices market taking into account growth factors, challenges, and other vital aspects.

Global Heart Valve Devices Market: Trends and Opportunities

Majorly fuelling the global market for heart valve devices is the rising prevalence of lifestyle diseases such as diabetes and obesity and lifestyle changes leading to cardiac diseases. High pressure jobs, sedentary lifestyle, and consumption of processed food that are synonymous with urban living are increasingly becoming major cause for diabetes and obesity that can further lead to heart conditions.

Apart from this, the increasing preference for minimally invasive procedures which lowers the risk of infections, need for blood transfusion, and even reduces hospital stay due to speedy recovery is serving to boost the demand for heart valve devices. Additionally, continued product upgrade by incorporating latest technologies leading to the advent of sophisticated heart valve devices is also serving to drive growth of this market.

Structural advances and design innovations of prosthetic heart valves have proven beneficial for valve replacement surgeries. This is further aiding the rise of heart valve devices market. The adoption of regenerative medicine and in-situ tissue engineering for the advent of bio absorbable heart valve devices is the focus of key players in this market. New players seeking entry into this market will strive to develop innovative products that will help them sustain the competition.

Global Heart Valve Devices Market: Geographical Analysis

The global market for heart valve devices witnesses the supremacy of North America because of early adoption of technologically advanced products and comparatively higher average selling prices of medical devices in the region.

Europe is the second-leading market for heart valve devices. The region’s growth is mainly attributed to numerous product launches, favorable government policies, and a large geriatric population susceptible to heart conditions.

Asia Pacific is likely to surpass other key regions vis-à-vis growth rate over the forecast period. The surging demand for heart valve devices in the region is mainly because of increasing incidence of cardiovascular diseases and improving healthcare infrastructure.

Global Heart Valve Devices Market: Competitive Landscape

The worldwide heart valve devices market comprises top-ranking companies such as Boston Scientific Corporation, Abbott, TTK Healthcare, Medtronic, Sorin Group, Lepu Medical Technology CO. Ltd., Edward Lifesciences Corporation, CryoLife Inc., JenaValve Technology Inc., Neovasc Inc., and Micro Interventional Devices Inc.

The presence of a large number of players accounts for the heart valve devices market to be fragmented in nature. Expansion of product portfolio and product innovation are the key focus of key players in this market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global heart valve devices market is segmented as follows;

by Type

  • Mechanical Heart Valves
    • Aortic Valves
    • Mitral Valves
  • Biological Heart Valves
    • Aortic Valves
    • Mitral Valves
    • Pulmonary Valves
    • Tricuspid Valves
  • Transcatheter Heart Valves
    • Aortic Valves
    • Mitral Valves
    • Pulmonary Valves

by End-user

  • Hospitals
  • Ambulatory Surgical Center

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Heart Valve Devices Market

4. Market Overview
     4.1. Introduction
            4.1.1. Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Market Dynamics
            4.2.1. Drivers
                     4.2.1.1. Longer life expectancy with growing aging population
                     4.2.1.2. High prevalence of heart valve diseases
                     4.2.1.3. Technological advancements
            4.2.2. Restraints
                     4.2.2.1. Stringent government approval process
                     4.2.2.2. High cost of minimally invasive procedures
            4.2.3. Opportunity
                     4.2.3.1. Emerging markets with high unmet needs
                     4.2.3.2. Effective treatment of vulvular disease
     4.3. Porter’s Five Force Analysis
     4.4. Market Outlook
     4.5. Pricing Analysis: Global Average Selling Price (US$), by Type, 2016 (A) and 2025 (F)

5. Global Heart Valve Devices Market, Technological Trends
     5.1. Developed Technologies Trends
     5.2. Transcathether Mitral Market Trends
     5.3. Valve-in-valve Replacement Trends
     5.4. Latest Technological Trends

6. Global Heart Valve Devices Market, Mergers and Acquisitions, 2010-2017

7. Global Heart Valve Devices Market, Regulation for Approval of New Medical Devices
     7.1. PMA Regulations
     7.2. CE Mark Regulations

8. Global Heart Valve Devices Market Analysis and Forecasts, By Type
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Value and Volume Forecast By Type, 2015–2025
            8.4.1. Mechanical Heart Valves
                     8.4.1.1. Aortic Valves
                     8.4.1.2. Mitral Valves
            8.4.2. Biological Heart Valves
                     8.4.2.1. Aortic Valves
                     8.4.2.2. Mitral Valves
                     8.4.2.3. Pulmonary Valves
                     8.4.2.4. Tricuspid Valves
            8.4.3. Transcatheter Heart Valves
                     8.4.3.1. Aortic Valves
                     8.4.3.2. Mitral Valves
                     8.4.3.3. Pulmonary Valves
     8.5. Market Attractiveness By Type

9. Global Heart Valve Devices Market Analysis and Forecasts, By End-user
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Key Trends
     9.4. Market Value Forecast By End-user, 2015–2025
            9.4.1. Hospitals
            9.4.2. Ambulatory Surgical Centers
     9.5. Market Attractiveness By End-user

10. Global Heart Valve Devices Market Analysis and Forecasts, By Region
     10.1. Key Findings
     10.2. Policies and Regulations
     10.3. Market Value Forecast By Region
            10.3.1. North America
            10.3.2. Europe
            10.3.3. Asia Pacific
            10.3.4. Latin America
            10.3.5. Middle East and Africa
     10.4. Market Attractiveness By Country/Region

11. North America Heart Valve Devices Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value and Volume Forecast By Type, 2015–2025
            11.2.1. Mechanical Heart Valves
                     11.2.1.1. Aortic Valves
                     11.2.1.2. Mitral Valves
            11.2.2. Biological Heart Valves
                     11.2.2.1. Aortic Valves
                     11.2.2.2. Mitral Valves
                     11.2.2.3. Pulmonary Valves
                     11.2.2.4. Tricuspid Valves
            11.2.3. Transcatheter Heart Valves
                     11.2.3.1. Aortic Valves
                     11.2.3.2. Mitral Valves
                     11.2.3.3. Pulmonary Valves
     11.3. Market Value Forecast By End-user, 2015–2025
            11.3.1. Hospitals
            11.3.2. Ambulatory Surgical Centers
     11.4. Market Value Forecast By Country, 2015–2025
            11.4.1. U.S.
            11.4.2. Canada
     11.5. Market Attractiveness Analysis
            11.5.1. By Type
            11.5.2. By End-user
            11.5.3. By Country

12. Europe Heart Valve Devices Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value and Volume Forecast By Type, 2015–2025
            12.2.1. Mechanical Heart Valves
                     12.2.1.1. Aortic Valves
                     12.2.1.2. Mitral Valves
            12.2.2. Biological Heart Valves
                     12.2.2.1. Aortic Valves
                     12.2.2.2. Mitral Valves
                     12.2.2.3. Pulmonary Valves
                     12.2.2.4. Tricuspid Valves
            12.2.3. Transcatheter Heart Valves
                     12.2.3.1. Aortic Valves
                     12.2.3.2. Mitral Valves
                     12.2.3.3. Pulmonary Valves
     12.3. Market Value Forecast By End-user, 2015–2025
            12.3.1. Hospitals
            12.3.2. Ambulatory Surgical Centers
     12.4. Market Value Forecast By Country, 2015–2025
            12.4.1. U.K.
            12.4.2. Germany
            12.4.3. France
            12.4.4. Italy
            12.4.5. Spain
            12.4.6. Russia
            12.4.7. Rest of Europe
     12.5. Market Attractiveness Analysis
            12.5.1. By Type
            12.5.2. By End-user
            12.5.3. By Country

13. Asia Pacific Heart Valve Devices Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Value Forecast By Type, 2015–2025
            13.2.1. Mechanical Heart Valves
                     13.2.1.1. Aortic Valves
                     13.2.1.2. Mitral Valves
            13.2.2. Biological Heart Valves
                     13.2.2.1. Aortic Valves
                     13.2.2.2. Mitral Valves
                     13.2.2.3. Pulmonary Valves
                     13.2.2.4. Tricuspid Valves
            13.2.3. Transcatheter Heart Valves
                     13.2.3.1. Aortic Valves
                     13.2.3.2. Mitral Valves
                     13.2.3.3. Pulmonary Valves
     13.3. Market Value Forecast By End-user, 2015–2025
            13.3.1. Hospitals
            13.3.2. Ambulatory Surgical Centers
     13.4. Market Value Forecast By Country, 2015–2025
            13.4.1. India
            13.4.2. China
            13.4.3. Japan
            13.4.4. Australia & New Zealand
            13.4.5. Rest of Asia Pacific
     13.5. Market Attractiveness Analysis
            13.5.1. By Type
            13.5.2. By End-user
            13.5.3. By Country

14. Latin America Heart Valve Devices Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Value and Volume Forecast By Type, 2015–2025
            14.2.1. Mechanical Heart Valves
                     14.2.1.1. Aortic Valves
                     14.2.1.2. Mitral Valves
            14.2.2. Biological Heart Valves
                     14.2.2.1. Aortic Valves
                     14.2.2.2. Mitral Valves
                     14.2.2.3. Pulmonary Valves
                     14.2.2.4. Tricuspid Valves
            14.2.3. Transcatheter Heart Valves
                     14.2.3.1. Aortic Valves
                     14.2.3.2. Mitral Valves
                     14.2.3.3. Pulmonary Valves
     14.3. Market Value Forecast By End-user, 2015–2025
            14.3.1. Hospitals
            14.3.2. Ambulatory Surgical Centers
     14.4. Market Value Forecast By Country, 2015–2025
            14.4.1. Brazil
            14.4.2. Mexico
            14.4.3. Rest of Latin America
     14.5. Market Attractiveness Analysis
            14.5.1. By Type
            14.5.2. By End-user
            14.5.3. By Country

15. Middle East and Africa Heart Valve Devices Market Analysis and Forecast
     15.1. Introduction
            15.1.1. Key Findings
     15.2. Market Value and Volume Forecast By Type, 2015–2025
            15.2.1. Mechanical Heart Valves
                     15.2.1.1. Aortic Valves
                     15.2.1.2. Mitral Valves
            15.2.2. Biological Heart Valves
                     15.2.2.1. Aortic Valves
                     15.2.2.2. Mitral Valves
                     15.2.2.3. Pulmonary Valves
                     15.2.2.4. Tricuspid Valves
            15.2.3. Transcatheter Heart Valves
                     15.2.3.1. Aortic Valves
                     15.2.3.2. Mitral Valves
                     15.2.3.3. Pulmonary Valves
     15.3. Market Value Forecast By End-user, 2015–2025
            15.3.1. Hospitals
            15.3.2. Ambulatory Surgical Centers
     15.4. Market Value Forecast By Country, 2015–2025
            15.4.1. South Africa
            15.4.2. GCC Countries
            15.4.3. Rest of Middle East and Africa
     15.5. Market Attractiveness Analysis
            15.5.1. By Type
            15.5.2. By End-user
            15.5.3. By Country

16. Competition Landscape
     16.1. Market Player – Competition Matrix (By Tier and Size of companies)
     16.2. Market Share Analysis By Company (2016)
     16.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            16.3.1. Abbott
                     16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.1.2 Financial Overview
                     16.3.1.3 Product Portfolio
                     16.3.1.4 SWOT Analysis
                     16.3.1.5 Strategic Overview
            16.3.2. Boston Scientific Corporation
                     16.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.2.2 Financial Overview
                     16.3.2.3 Product Portfolio
                     16.3.2.4 SWOT Analysis
                     16.3.2.5 Strategic Overview
            16.3.3. CryoLife, Inc.
                     16.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.3.2 Financial Overview
                     16.3.3.3 Product Portfolio
                     16.3.3.4 SWOT Analysis
                     16.3.3.5 Strategic Overview
            16.3.4. Edward Lifesciences Corporation
                     16.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.4.2 Financial Overview
                     16.3.4.3 Product Portfolio
                     16.3.4.4 SWOT Analysis
                     16.3.4.5 Strategic Overview
            16.3.5. JenaValve Technology, Inc.
                     16.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.5.2 Financial Overview
                     16.3.5.3 Product Portfolio
                     16.3.5.4 SWOT Analysis
                     16.3.5.5 Strategic Overview
            16.3.6. Medtronic
                     16.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.6.2 Financial Overview
                     16.3.6.3 Product Portfolio
                     16.3.6.4 SWOT Analysis
                     16.3.6.5 Strategic Overview
            16.3.7. SYMETIS
                     16.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.7.2 Financial Overview
                     16.3.7.3 Product Portfolio
                     16.3.7.4 SWOT Analysis
                     16.3.7.5 Strategic Overview
            16.3.8. Neovasc, Inc.
                     16.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.8.2 Financial Overview
                     16.3.8.3 Product Portfolio
                     16.3.8.4 SWOT Analysis
                     16.3.8.5 Strategic Overview
            16.3.9. Sorin Group (LivaNova PLC)
                     16.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.9.2 Financial Overview
                     16.3.9.3 Product Portfolio
                     16.3.9.4 SWOT Analysis
                     16.3.9.5 Strategic Overview
            16.3.10. Micro Interventional Devices, Inc.
                     16.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.10.2 Financial Overview
                     16.3.10.3 Product Portfolio
                     16.3.10.4 SWOT Analysis
                     16.3.10.5 Strategic Overview
            16.3.11. XELTIS
                     16.3.11.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.11.2 Financial Overview
                     16.3.11.3 Product Portfolio
                     16.3.11.4 SWOT Analysis
                     16.3.11.5 Strategic Overview
            16.3.12. TTK HealthCare
                     16.3.12.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.12.2 Financial Overview
                     16.3.12.3 Product Portfolio
                     16.3.12.4 SWOT Analysis
                     16.3.12.5 Strategic Overview
            16.3.13. Lepu Medical Technology (Beijing) Co., Ltd. (Lepu Medical Group)
                     16.3.13.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.13.2 Financial Overview
                     16.3.13.3 Product Portfolio
                     16.3.13.4 SWOT Analysis
                     16.3.13.5 Strategic Overview
            16.3.14. Auto Tissue Berlin GmbH
                     16.3.14.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.14.2 Financial Overview
                     16.3.14.3 Product Portfolio
                     16.3.14.4. SWOT Analysis
                     16.3.14.5 Strategic Overview
            16.3.15. Novostia SA
                     16.3.15.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     16.3.15.2 Financial Overview
                     16.3.15.3 Product Portfolio
                     16.3.15.4. SWOT Analysis
                     16.3.15.5 Strategic Overview

17. Key Take Aways

List of Tables

Table 01: Heart Valve Devices- Global Average Selling Price (US$), by Type, 2016 (A) & 2025 (F)
Table 02: Clinical Trials for Transcatheter Aortic Valve Intervention (TAVI), by Company
Table 03: Clinical Trials for Transcatheter Mitral Valve Devices, by Company
Table 04: Clinical Trials for Transcatheter Mitral Valve Devices, by Company
Table 05: Published Patent Details for Company XELTIS, 2014-2017
Table 06: Clinical Trial Details of Xeltis Bioabsorb-able Pulmonary Valved Conduit, 2017
Table 07: Details of the Project – ImaValve, November 2016
Table 08: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2017
Table 09: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2017
Table 10: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2016 
Table 11: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2016 
Table 12: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2015
Table 13: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2015
Table 14: Overview: Global Heart Valve Devices Market - Merger, by Company, 2015
Table 15: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2010–2013
Table 16: Overview: Global Heart Valve Devices Market - Acquisitions, by Company, 2010–2013
Table 17: Heart Valve Devices Cleared or Approved by U.S. FDA, 2017-2015
Table 18: Medical Device Classification as per U.S. FDA
Table 19: Supplements for pre-market approval, by Type of Supplement Process, 1986-1997
Table 20: Medical Device Classification as per European Commission (EC)
Table 21: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Type, 2015–2025
Table 22: Global Heart Valve Devices Market Volume (Units) Forecast, by Type, 2015–2025
Table 23: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Mechanical Heart Valves, 2015–2025
Table 24: Global Heart Valve Devices Market Volume (Units) Forecast, by Mechanical Heart Valves, 2015–2025
Table 25: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Heart Valves, 2015–2025
Table 26: Global Heart Valve Devices Market Volume (Units) Forecast, by Biological Heart Valves, 2015–2025
Table 27: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Transcatheter Heart Valves, 2015–2025
Table 28: Global Heart Valve Devices Market Volume (Units) Forecast, by Transcatheter Heart Valves, 2015–2025
Table 29: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2015-2025
Table 30: Global Heart Valve Devices Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 31: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 32: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type, 2015–2025
Table 33: North America Heart Valve Devices Market Volume (Units) Forecast, by Type, 2015–2025
Table 34: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Mechanical Heart Valves, 2015–2025
Table 35: North America Heart Valve Devices Market Volume (Units) Forecast, by Type – Mechanical Heart Valves, 2015–2025
Table 36: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Biological Heart Valves, 2015–2025
Table 37: North America Heart Valve Devices Market Volume (Units) Forecast, by Type – Biological Heart Valves, 2015–2025
Table 38: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Transcatheter Heart Valves, 2015–2025
Table 39: North America Heart Valve Devices Market Volume (Units) Forecast, by Type – Transcatheter Heart Valves, 2015–2025
Table 40: North America Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 41: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 42: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Type, 2015–2025
Table 43: Europe Heart Valve Devices Market Volume (Units) Forecast, by Type, 2015–2025
Table 44: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Mechanical Heart Valves, 2015–2025
Table 45: Europe Heart Valve Devices Market Volume (Units) Forecast, by Mechanical Heart Valves, 2015–2025
Table 46: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Heart Valves, 2015–2025
Table 47: Europe Heart Valve Devices Market Volume (Units) Forecast, by Biological Heart Valves, 2015–2025
Table 48: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by Transcatheter Heart Valves, 2015–2025
Table 49: Europe Heart Valve Devices Market Volume (Units) Forecast, by Transcatheter Heart Valves, 2015–2025
Table 50: Europe Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 51: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 52: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Type, 2015–2025
Table 53: Asia Pacific Heart Valve Devices Market Volume (Units) Forecast, by Type, 2015–2025
Table 54: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Mechanical Heart Valves, 2015–2025
Table 55: Asia Pacific Heart Valve Devices Market Volume (Units) Forecast, by Mechanical Heart Valves, 2015–2025
Table 56: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Biological Heart Valves, 2015–2025
Table 57: Asia Pacific Heart Valve Devices Market Volume (Units) Forecast, by Biological Heart Valves, 2015–2025
Table 58: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by Transcatheter Heart Valves, 2015–2025
Table 59: Asia Pacific Heart Valve Devices Market Volume (Units) Forecast, by Transcatheter Heart Valves, 2015–2025
Table 60: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 61: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 62: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type, 2015–2025
Table 63: Latin America Heart Valve Devices Market Volume (Units) Forecast, by Type, 2015–2025
Table 64: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Mechanical Heart Valves, 2015–2025
Table 65: Latin America Heart Valve Devices Market Volume (Units) Forecast, by Type – Mechanical Heart Valves, 2015–2025
Table 66: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Biological Heart Valves, 2015–2025
Table 67: Latin America Heart Valve Devices Market Volume (Units) Forecast, by Type – Biological Heart Valves, 2015–2025
Table 68: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Transcatheter Heart Valves, 2015–2025
Table 69: Latin America Heart Valve Devices Market Volume (Units) Forecast, by Type – Transcatheter Heart Valves, 2015–2025
Table 70: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 71: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 72: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Type, 2015–2025
Table 73: Middle East & Africa Heart Valve Devices Market Volume (Units) Forecast, by Type, 2015–2025
Table 74: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Mechanical Heart Valves, 2015–2025
Table 75: Middle East & Africa Heart Valve Devices Market Volume (Units) Forecast, by Type – Mechanical Heart Valves, 2015–2025
Table 76: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Biological Heart Valves, 2015–2025
Table 77: Middle East & Africa Heart Valve Devices Market Volume (Units) Forecast, by Type – Biological Heart Valves, 2015–2025
Table 78: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by Type – Transcatheter Heart Valves, 2015–2025
Table 79: Middle East & Africa Heart Valve Devices Market Volume (Units) Forecast, by Type – Transcatheter Heart Valves, 2015–2025
Table 80: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast, by End-user, 2015–2025

List of Figures

Figure 01: Global Heart Valve Devices Market Value Share, by Type, 2017 and 2025
Figure 02: Global Mechanical Heart Valve Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 03: Global Biological Heart Valve Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 04: Global Transcatheter Heart Valve Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 05: Global Heart Valve Devices Market Attractiveness, by Type, 2017-2025
Figure 06: Global Heart Valve Devices Market Value Share,
Figure 07: Global Heart Valve Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015–2025
Figure 08: Global heart valve devices market Value (US$ Mn) and
Figure 09: Global heart valve devices market Attractiveness,
Figure 10: Global Heart Valve Devices Market Value Share, by Region, 2017 and 2025
Figure 11: Global Heart Valve Devices Market Attractiveness, by Region, 2017–2025
Figure 13: North America Heart Valve Devices Market Value Share, by Country, 2017 and 2025
Figure 12: North America Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 14: North America Heart Valve Devices Market Attractiveness, by Country, 2017–2025
Figure 15: North America Heart Valve Devices Market Value Share, by Type, 2017 and 2025
Figure 16: North America Heart Valve Devices Market Attractiveness, by Type, 2017–2025
Figure 17: North America Heart Valve Devices Market Value Share, by End-user, 2017 and 2025
Figure 18: North America Heart Valve Devices Market Attractiveness, by End-user, 2017–2025
Figure 19: Europe Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 20: Europe Heart Valve Devices Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 21: Europe Heart Valve Devices Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 22: Europe Heart Valve Devices Market Value Share, by Type, 2017 and 2025
Figure 23: Europe Heart Valve Devices Market Attractiveness, by Type, 2017–2025
Figure 24: Europe Heart Valve Devices Market Value Share, by End-user, 2017 and 2025
Figure 25: Europe Heart Valve Devices Market Attractiveness, by End-user, 2017–2025
Figure 26: Asia Pacific Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 27: Asia Pacific Heart Valve Devices Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 28: Asia Pacific Heart Valve Devices Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 29: Asia Pacific Heart Valve Devices Market Value Share, by Type, 2017 and 2025
Figure 30: Asia Pacific Heart Valve Devices Market Attractiveness, by Type, 2017–2025
Figure 31: Asia Pacific Heart Valve Devices Market Value Share, by End-user, 2017 and 2025
Figure 32: Asia Pacific Heart Valve Devices Market Attractiveness, by End-user, 2017–2025
Figure 33: Latin America Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 34: Latin America Heart Valve Devices Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 35: Latin America Heart Valve Devices Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 36: Latin America Heart Valve Devices Market Value Share, by Type, 2017 and 2025
Figure 37: Latin America Heart Valve Devices Market Attractiveness, by Type, 2017–2025
Figure 38: Latin America Heart Valve Devices Market Value Share, by
Figure 39: Latin America Heart Valve Devices Market Attractiveness, by End-user, 2017–2025
Figure 40: Middle East & Africa Heart Valve Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 41: Middle East & Africa Heart Valve Devices Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 42: Middle East & Africa Heart Valve Devices Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 43: Middle East & Africa Heart Valve Devices Market Value Share, by Type, 2017 and 2025
Figure 44: Middle East & Africa Heart Valve Devices Market Attractiveness, by Type, 2017–2025
Figure 45: Middle East & Africa Heart Valve Devices Market Value Share, by End-user, 2017 and 2025
Figure 46: Middle East & Africa Heart Valve Devices Market Attractiveness, by End-user, 2017–2025
Figure 47: Global Heart Valve Devices Market Share, by Company, 2016

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Heart Valve Devices Market